Dale Bredesen, MD, will be answering your Cognitive Decline and Alzheimer’s-related questions live on Facebook following the September offering of Reversing Cognitive Decline: Advanced Clinical Training in MCI and Early Alzheimer's Disease.
Dr. Dale Bredesen, founding president and CEO of the Buck Institute for Research on Aging, has developed a new approach to the treatment of Alzheimer’s disease, and this approach has led to the first description of a reversal of symptoms in patients with mild cognitive impairment (MCI) and early Alzheimer’s disease.
September 9-10, the Institute for Functional Medicine, in collaboration with Dale Bredesen, MD, and MPI Cognition, will present a two-day CME program in which attendees will learn a multi-pronged treatment strategy for patients with these conditions. Using a systems biology approach, attendees will learn to assess patients for MCI and early AD, stratify them based on the likely causes of their dysfunction, and apply a multimodal protocol to individualize treatments for each patient that address the appropriate underlying causes. In this way, you can arrest cognitive decline and in many cases even reverse it.
Click here for more information on Reversing Cognitive Decline: Advanced Clinical Training in MCI and Early Alzheimer's Disease - In collaboration with Dale Bredesen, MD, and MPI Cognition.
Dale Bredesen, MD, has pioneered personalized lifestyle interventions for cognitive decline and Alzheimer's disease. In his new book, The End of Alzheimer's, Dr. Bredesen covers this topic in depth. Learn more about Dale Bredesen, MD, and download a free chapter of his new book at IFM.org/EndofAlzheimers.